ロード中...

Rapid Disease Control in First-Line Therapy-Resistant Mucous Membrane Pemphigoid and Bullous Pemphigoid with Omalizumab as Add-On Therapy: A Case Series Of 13 Patients

The role of IgE autoantibodies has been demonstrated in the pathogenesis of bullous pemphigoid for many years. Recently, omalizumab (OMZ), a humanized monoclonal anti-IgE antibody that depletes total serum IgE, has been used off-label in a few case series of bullous pemphigoids demonstrating a rapid...

詳細記述

保存先:
書誌詳細
主要な著者: Marina Alexandre, Gérôme Bohelay, Thomas Gille, Christelle Le Roux-Villet, Isaac Soued, Florence Morin, Frédéric Caux, Sabine Grootenboer-Mignot, Catherine Prost-Squarcioni
フォーマット: Artigo
言語:Inglês
出版事項: Frontiers Media S.A. 2022-04-01
シリーズ:Frontiers in Immunology
主題:
オンライン・アクセス:https://www.frontiersin.org/articles/10.3389/fimmu.2022.874108/full
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!